Pneumococcal vaccine - Chengdu Institute of Biological Products

Drug Profile

Pneumococcal vaccine - Chengdu Institute of Biological Products

Alternative Names: 23-valent Pneumococcal polysaccharide vaccine - Chengdu Institute of Biological Products; 23vPPV; Pneumococcal 23-valent polysaccharide vaccine - Chengdu Institute of Biological Products

Latest Information Update: 05 Mar 2014

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Chengdu Institute of Biological Products
  • Class Pneumococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pneumococcal infections

Most Recent Events

  • 31 Dec 2006 Launched for Pneumococcal infections (prevention) in China (IM)
  • 31 Dec 1996 Investigation in Pneumococcal infections (prevention) in China (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top